Drug · DIN 02299844
CELSENTRI
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 30, 2014; first marketed September 26, 2007.
- Drug Identification Number (DIN)
- 02299844
- Company (DIN owner)
- Viiv Healthcare UlcMontreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Maraviroc J05AX09
- Class
- Human
- Record last updated
- June 12, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| MARAVIROC | 150 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 29, 2014: NOC 16100Supplement to a New Drug Submission (SNDS) · Addition of long-term data from three phase 2b/3 trials and updates to the pm in the adverse reaction section
- December 21, 2009: NOC 10880New Drug Submission (NDS) · Manufacturer name change
- September 21, 2007: NOC 9043New Drug Submission (NDS)
Other DINs named CELSENTRI
- DIN 02299852 · Marketed